Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)

Product Details
Customization: Available
Certification: ISO
Assay Method: HPLC
Manufacturer/Factory & Trading Company
Gold Member Since 2007

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (16)
  • Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)
  • Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)
  • Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)
  • Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)
  • Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)
  • Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)
Find Similar Products

Basic Info.

Model NO.
Grj-Kae
Application Form
Tablet
Application
Health Care Products
State
Powder
Extract Source
Kaempferia Extract
Odor
Characteristic
Delivery
in Time
Taste
Characteristic
Test Method
HPLC
Transport Package
25kg drum
Specification
ISO
Trademark
Gorunjie
Origin
China
HS Code
2932999099
Production Capacity
300kg

Product Description

Assay: 10-98%
Source: Kaempferia galanga L
Molecular Formula: C15H10O6
CAS: 520-18-3
Appearance: Yellow Crystalline powder
Kaempferol, Kaempferia Extract 10-98% (Grj-Kae)

Kaempferol belongs to the flavonols, yellow needle crystal. It has anti-cancer, anti - fertility, anti - epileptic, anti - inflammatory, anti - oxidant, antispasmodic, anti - ulcer, diuretic, relieving cough.

Keampferol is a strong antioxidant and helps to prevent oxidative damage of our cells, lipids and DNA. Kaempferol seems to prevent arteriosclerosis by inhibiting the oxidation of low density lipoprotein and the formation of platelets in the blood. Studies have also confirmed that kaempferol acts as a chemopreventive agent, which means that it inhibits the formation of cancer cells.

An in vitro study by Jan Kowalski et al (Pharmacological Reports, 2005) showed that kaempferol inhibits monocyte chemoattractant protein (MCP-1). MCP-1 plays a role in the initial steps of atherosclerotic plaque formation.

The flavonoids kaempferol and quercetin seems to act synergistically in reducing cell proliferation of cancer cells, meaning that the combined treatments with quercetin and kaempferol are more effective than the additive effects of each flavonoid. This was a conclusion from a study by ML Ackland et al (In Vivo, Feb 2005) titled "Synergistic antiproliferative action of the flavonols quercitin and kaempferol in cultured human cancer cell lines".

A study "Inhibition of P-glycoprotein function and expression by kaempferol and quercetin" by the Chiang Mai University, Thailand, found that kaempferol can help to fight cancer because it reduces the resistance of cancer cells to anti-cancer drugs such as vinbalstine.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier